Table 1.
Variable Name | Overall Sarcoidosis (N=609 051) | With Cardiovascular Manifestations (n=188 438) | Without Cardiovascular Manifestations (n=420 613) |
---|---|---|---|
Age, y | 55±14 | 59±14 | 53±13 |
Sex, % | |||
Male | 32.8 | 33.9 | 32.3 |
Female | 67.2 | 66.1 | 67.7 |
Race, % | |||
White | 43.9 | 40.5 | 45.4 |
Black | 49.5 | 54.3 | 47.3 |
Other | 6.6 | 5.2 | 7.3 |
Comorbidities, % | |||
Diabetes mellitus | 24.9 | 29.3 | 22.9 |
Hypertension | 52.9 | 58.5 | 50.4 |
Liver disease | 4.5 | 4.2 | 4.7 |
Fluid and electrolyte disorder | 24.2 | 29.2 | 22 |
Neurological disorder | 6.8 | 6.6 | 6.9 |
Coagulopathy | 4.6 | 5.7 | 4.1 |
Chronic pulmonary disease | 29.0 | 35.8 | 25.9 |
Anemia | 18.1 | 20.8 | 16.9 |
Solid tumor with metastasis | 1.4 | 1.3 | 1.4 |
Metastatic cancer | 1.6 | 1.2 | 1.8 |
Pulmonary circulation disorders | 6.3 | 18.9 | 0.6 |
Renal failure | 12.2 | 19.4 | 9.0 |
Hospital region, % | |||
Northeast | 25.1 | 23.5 | 25.7 |
Midwest | 24.1 | 24.9 | 23.8 |
South | 40.4 | 40.8 | 40.2 |
West | 10.4 | 10.8 | 10.3 |
Hospital type, % | |||
Urban | 91.3 | 91.8 | 91.0 |
Rural | 8.7 | 8.2 | 9.0 |
Data are presented as mean±SD or percentage.